Overall, the evidence of increased prevalence of cognitive impairment and neuropsychiatric disorders in DM patients in one hand, and the role of BDNF in mediating glucose-associated metabolic pathways in the other hand imply that DM might impact the maintenance of BDNF levels in body fluids. This evidence concerns the gene BDNF and Cognitive impairment.